Homeopathic Drug Product Safety, Quality, and Transparency Act

# Homeopathic Drug Product Safety, Quality, and Transparency Act Summary **What the Bill Would Do:** This bill would establish new regulatory requirements for homeopathic products sold in the United States. Currently, the FDA oversees homeopathic drugs with minimal oversight compared to conventional pharmaceuticals. This legislation would likely impose stricter quality standards, safety testing, and labeling requirements on homeopathic manufacturers to ensure consumers have accurate information about these products. **Who It Affects:** The bill would primarily affect manufacturers and sellers of homeopathic products (remedies made through extreme dilution of substances), as well as consumers who purchase these items.

Homeopathic remedies are widely available in drugstores and health food stores and are used by millions of Americans seeking alternative health solutions. **Current Status:** As of now, HR 7050 remains in committee, meaning it has not yet been debated or voted on by the full House of Representatives. The bill was introduced by Representative Pete Sessions (R-TX) in the 119th Congress but has not advanced beyond the initial committee review stage.